Biomarkers for dementia: too soon for routine clinical use

The Lancet Neurology

Fecha de publicación: Novembre 2020


Autores: Jeremy D Isaacs, Marianne Boenink

Background: Dementia biomarkers are valuable research tools, providing glimpses of brain pathology and function previously only available from post-mortem investigations. Before large-scale adoption in clinical practice, however, these technologies should show that they contribute meaningfully, cost-effectively, and sustainably to patient care.

Seguir Leyendo

Enviar comentario